Hereditary nonpolyposis colorectal cancer surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (13 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hereditary nonpolyposis colorectal cancer}} | {{Hereditary nonpolyposis colorectal cancer}} | ||
{{CMG}}{{AE}}{{MV}} | {{CMG}}{{AE}}{{MV}}{{Akram}} | ||
==Overview== | ==Overview== | ||
Surgery is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. | [[Surgery]] is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. [[Surgery|Surgical]] [[resection]] is recommended for [[Patient|patients]] with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]]. [[colectomy|Subtotal colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and [[Surgery|postsurgical]] [[Endoscopy|endoscopic]] [[rectal]] surveillance are advised when [[colorectal cancer]] develops in the setting of hereditary nonpolyposis colorectal cancer. | ||
==Surgery== | ==Surgery== | ||
*Surgical resection is recommended | *[[Surgery|Surgical]] [[resection]] is recommended for [[Patient|patients]] with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous [[colorectal cancer]]. | ||
*Subtotal colectomy with | *Common [[Surgery|surgical]] techniques for the [[resection]] of hereditary nonpolyposis colorectal cancer include: | ||
:*[[Colectomy|Subtotal colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and [[Surgery|postsurgical]] [[Endoscopy|endoscopic]] [[rectal]] surveillance ([[Surgery|surgical]] treatment of choice in the setting of hereditary nonpolyposis colorectal cancer) | |||
:*[[Proctocolectomy]] with [[ileostomy]] | |||
* | :*[[Colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] and/or [[proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch]]"<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref> | ||
* | :*[[Proctocolectomy]] with [[ileostomy]] | ||
* | :*[[Colectomy]] with [[Ileum|ileo]]-[[rectal]] [[anastomosis]] | ||
* | :*[[Proctocolectomy]] with [[Ileo-anal pouch|ileo-anal "pouch"]] S, J, W or H<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref> | ||
* | :*[[Hysterectomy]] and adnexectomy (in [[female]] hereditary nonpolyposis colorectal cancer [[Patient|patients]]) due to increased risk of primary [[Endometrial cancer|endometrial]] and [[Ovarian cancer|ovarian cancers]] | ||
:*[[Endoscopy|Endoscopic]] [[polypectomy]] (recommended in the case of [[Polyp|polyps]] which are [[benign]] and non-recurrent) | |||
*Endoscopic polypectomy | *[[Surgery|Surgical]] procedures for hereditary nonpolyposis colorectal cancer are characterized by increasing frequency of [[Complication (medicine)|complications]]. | ||
*The high proportion of synchronous tumors (more than 15% of patients at the time of diagnosis) or metachronous tumors (about 45% during 10 years following surgery of the primary tumor) | *Complex [[Surgery|surgical]] procedures are related with higher number of [[Complication (medicine)|complications]], but lower recurrence rates. | ||
*[[Prophylaxis|Prophylactic]] [[colectomy]] should be considered in [[Patient|patients]] with [[Adenoma|adenomas]] that are multiple and/or recurrent and/or of a significant degree of [[dysplasia]] and/or [[Villous adenoma|villous]]. | |||
*The high proportion of [[Synchronicity|synchronous]] [[Tumor|tumors]] (more than 15% of [[Patient|patients]] at the time of [[diagnosis]]) or metachronous [[Tumor|tumors]] (about 45% during 10 years following [[surgery]] of the primary [[tumor]]) [[Indication (medicine)|indicates]] [[Prevention (medical)|preventive]] [[surgery]] as for [[surgery]] in [[Patient|patients]] of hereditary nonpolyposis colorectal cancer.<ref name="lynch">Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer). Hered Cancer Clin Pract. 2008;6(2):99-102.</ref> | |||
Common [[Surgery|surgical]] [[Complication (medicine)|complications]] of hereditary nonpolyposis colorectal cancer may include: | |||
*[[Urinary system|Urinary tract]] abnormalities | |||
*[[Sexual dysfunction]] | |||
==Prophylactic Surgery== | ==Prophylactic Surgery== | ||
*The feasibility of prophylactic surgery of the colon, uterus, and ovaries | *The feasibility of [[Prophylaxis|prophylactic]] [[surgery]] of the [[Colon (anatomy)|colon]], [[uterus]], and [[Ovary|ovaries]] varies from [[patient]] to [[patient]].<ref name="pmid21037810">{{cite journal |vauthors=Gryfe R |title=Inherited colorectal cancer syndromes |journal=Clin Colon Rectal Surg |volume=22 |issue=4 |pages=198–208 |year=2009 |pmid=21037810 |pmc=2796102 |doi=10.1055/s-0029-1242459 |url=}}</ref> | ||
*In some cases screen-detected family members and symptomatic individuals (young adults) are eligible for prophylactic colorectal surgery. | *In some cases screen-detected [[family]] members and [[symptomatic]] individuals (young [[Adult|adults]]) are eligible for [[Prophylaxis|prophylactic]] [[colorectal surgery]]. | ||
*[[Prophylaxis|Prophylactic]] [[surgery]] should not be recommended for [[Patient|patients]] without any [[Pathology|pathological]] changes in the [[Colon (anatomy)|colon]] even if such individuals are [[Carrier|carriers]] of a [[mutation]].<ref name="pmid16421367">{{cite journal |vauthors=Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH |title=Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome |journal=N. Engl. J. Med. |volume=354 |issue=3 |pages=261–9 |year=2006 |pmid=16421367 |doi=10.1056/NEJMoa052627 |url=}}</ref> | |||
==References== | ==References== | ||
| Line 43: | Line 43: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 13:56, 30 April 2019
|
Hereditary Nonpolyposis Colorectal Cancer Microchapters |
|
Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary nonpolyposis colorectal cancer surgery On the Web |
|
American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer surgery |
|
Hereditary nonpolyposis colorectal cancer surgery in the news |
|
Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer |
|
Risk calculators and risk factors for Hereditary nonpolyposis colorectal cancer surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]Ali Akram, M.B.B.S.[3]
Overview
Surgery is the mainstay of treatment for hereditary nonpolyposis colorectal cancer. Surgical resection is recommended for patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer. Subtotal colectomy with ileo-rectal anastomosis and postsurgical endoscopic rectal surveillance are advised when colorectal cancer develops in the setting of hereditary nonpolyposis colorectal cancer.
Surgery
- Surgical resection is recommended for patients with hereditary nonpolyposis colorectal cancer because of the high rate of metachronous colorectal cancer.
- Common surgical techniques for the resection of hereditary nonpolyposis colorectal cancer include:
- Subtotal colectomy with ileo-rectal anastomosis and postsurgical endoscopic rectal surveillance (surgical treatment of choice in the setting of hereditary nonpolyposis colorectal cancer)
- Proctocolectomy with ileostomy
- Colectomy with ileo-rectal anastomosis and/or proctocolectomy with ileo-anal "pouch"[1]
- Proctocolectomy with ileostomy
- Colectomy with ileo-rectal anastomosis
- Proctocolectomy with ileo-anal "pouch" S, J, W or H[1]
- Hysterectomy and adnexectomy (in female hereditary nonpolyposis colorectal cancer patients) due to increased risk of primary endometrial and ovarian cancers
- Endoscopic polypectomy (recommended in the case of polyps which are benign and non-recurrent)
- Surgical procedures for hereditary nonpolyposis colorectal cancer are characterized by increasing frequency of complications.
- Complex surgical procedures are related with higher number of complications, but lower recurrence rates.
- Prophylactic colectomy should be considered in patients with adenomas that are multiple and/or recurrent and/or of a significant degree of dysplasia and/or villous.
- The high proportion of synchronous tumors (more than 15% of patients at the time of diagnosis) or metachronous tumors (about 45% during 10 years following surgery of the primary tumor) indicates preventive surgery as for surgery in patients of hereditary nonpolyposis colorectal cancer.[1]
Common surgical complications of hereditary nonpolyposis colorectal cancer may include:
- Urinary tract abnormalities
- Sexual dysfunction
Prophylactic Surgery
- The feasibility of prophylactic surgery of the colon, uterus, and ovaries varies from patient to patient.[2]
- In some cases screen-detected family members and symptomatic individuals (young adults) are eligible for prophylactic colorectal surgery.
- Prophylactic surgery should not be recommended for patients without any pathological changes in the colon even if such individuals are carriers of a mutation.[3]
References
- ↑ 1.0 1.1 1.2 Kladny J, Lubinski J. Lynch syndrome (hereditary nonpolyposis colorectal cancer ). Hered Cancer Clin Pract. 2008;6(2):99-102.
- ↑ Gryfe R (2009). "Inherited colorectal cancer syndromes". Clin Colon Rectal Surg. 22 (4): 198–208. doi:10.1055/s-0029-1242459. PMC 2796102. PMID 21037810.
- ↑ Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006). "Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome". N. Engl. J. Med. 354 (3): 261–9. doi:10.1056/NEJMoa052627. PMID 16421367.